Jubilant Pharmova informs about disclosure

17 Jan 2025 Evaluate

In accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jubilant Pharmova has informed that the Company’s subsidiary Jubilant Cadista Pharmaceuticals Inc., (Jubilant Cadista)’s solid oral formulations facility at Salisbury, Maryland, USA was inspected by the United States Food and Drug Administration (USFDA). USFDA has issued five observations with no repeat observations. Jubilant Cadista will submit an appropriate action plan to the USFDA on these observations within stipulated time. Going forward the said facility is not expected to manufacture any products as it has closed manufacturing operations as was referenced in the previous disclosure dated April 18, 2024. The Company has received communication from USFDA at 1.17 am (IST) on Thursday, January 16, 2025.

The above information is a part of company’s filings submitted to BSE.

Jubilant Pharmova Share Price

968.25 20.00 (2.11%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×